NRX Pharmaceuticals Inc.
Organization details
- Legal name
- NRX Pharmaceuticals Inc.
- Former names
- Big Rock Partners Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Wilmington
- Headquarters state / province
- Delaware
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NRXP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001719406
- EIN
- 82-2844431
Board of directors
-
Aaron Gorovitz · DirectorSince 2023
-
Chaim Hurvitz · DirectorSince 2023
-
Dennis McBride · DirectorSince 2024
-
Janet Rehnquist · DirectorSince 2023
-
Jonathan C. Javitt · Director · CEO and ChairmanSince 2023
-
Patrick John Flynn · DirectorSince 2025
Chief executives
Director election results
Annual meeting of March 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 17, 2024 | Jonathan C. Javitt Director, Officer (Chairman and Chief Scientist), 10% owner | Open-market purchase | +40,000 | $1.17 | $46,800 |
| Aug 30, 2023 | Aaron Gorovitz Director | Open-market purchase | +35,000 | $0.32 | $11,200 |
| Aug 30, 2023 | Chaim Hurvitz Director | Open-market purchase | +70,000 | $0.29 | $20,300 |
| Aug 23, 2023 | Jonathan C. Javitt Director, Officer (Chief Scientist), 10% owner | Open-market purchase | +100,000 | $0.33 | $33,000 |
| Aug 22, 2023 | Jonathan C. Javitt Director, Officer (Chief Scientist), 10% owner | Open-market purchase | +200,000 | $0.32 | $64,000 |
| Dec 14, 2022 | Jonathan C. Javitt Director, 10% owner | Gift | −300,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about NRX Pharmaceuticals Inc.
Who is the CEO of NRX Pharmaceuticals Inc.?
Jonathan C. Javitt is NRX Pharmaceuticals Inc.'s CEO and Chairman.
How many directors are on NRX Pharmaceuticals Inc.'s board?
NRX Pharmaceuticals Inc.'s board has 6 directors: Aaron Gorovitz, Chaim Hurvitz, Dennis McBride, Janet Rehnquist, Jonathan C. Javitt and Patrick John Flynn.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="nrx-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.